Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression.
Risaliti
A
A
Department of Surgery, Transplantation Unit, University of Udine, Udine, Italy. a.risaliti@med.uniud.it
Baccarani
U
U
Vianello
V
V
Donini
A
A
Adani
G L
GL
Sainz
M
M
Montanaro
D
D
Alessandrini
V
V
Bresadola
F
F
D002318:Cardiovascular Diseases / Q000453:epidemiology*; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000453:epidemiology; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology*; D008659:Metabolic Diseases / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus